Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/22114792
Conclusion of this study
Concerning oxidative status, plasma reactive oxygen species levels increased in the placebo group v. the n-3 group at the later treatment times. Hydroxynonenal levels increased in the placebo group during the study, while they stabilised in the n-3 group. Our data confirm that the continual assumption of EPA plus DHA determined an anti-inflammatory and anti-oxidative action which could be considered a preliminary goal in anti-cachectic therapy.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study